期刊文献+

胃肠道间质瘤与酪氨酸激酶抑制剂 被引量:2

下载PDF
导出
摘要 胃肠道间质瘤 (GISTs)是发生于消化道的一种非神经源性、非平滑肌源性的独立疾病。在GISTs中存在不同位点的c kit功能获得性突变 ,激活其产物KIT的酪氨酸激酶活性 ,从而活化多条信号转导通路 ,诱导细胞增殖与恶变。STI5 71是人工合成的一种酪氨酸激酶抑制剂 ,抑制激酶和底物的磷酸化。STI5 71治疗GISTs的Ⅰ ,Ⅱ期临床试验疗效显著 。
作者 冯菲
出处 《国外医学(生理病理科学与临床分册)》 2003年第2期142-145,共4页 Foreign Medical Sciences(Pathophysiology and Clinical Medicine)
基金 国家自然科学基金 (3 0 0 70 743 )
  • 相关文献

参考文献20

  • 1Makku M, James MM, Maarit SR, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery : Clinicopathologic and immunohisto- chemical study of 26 cases [J]. Am J Surg Pathol, 1999,23(9) :1109-1118. 被引量:1
  • 2Michael CH,Charles DB,Brian JD,et al. Inhibition of KIT tyrosine kinase activity : a novel molecular approach to the treatment of KIT-positive malignancie [J]. J Clini Oncol, 2002,20 (6) :1692-17. 被引量:1
  • 3Mittinen M, Sobin LH. Gastrointestinal stromal tumors in the appendix:a clinicopathologic and immunohistochemical study of four cases[J]. Am J Surg Pathol, 2001,25( 11 ) :1433-1437. 被引量:1
  • 4Tadashi H, Yoshihiro M, Tadakazu S, et al. Gastrointestinal stromal tumor: Consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade[ J].Hum Patho1,2002,33 (6) :669-676. 被引量:1
  • 5Franquemont DW. Diffrentiation and risk assessment of gastro- intestinal stromal tumors[J]. Am J Clin Pathol,1995, 103( 1 ) : 41-47. 被引量:1
  • 6Jacqueline KT, Ronald ES, Carolyn M, et al. Gastric stromal tumors : A clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors[ J]. Am J Surg Pathol,2002,26(6) :705-714. 被引量:1
  • 7Pierre R, Katharina G, Reza P, et al. Immuno- phenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: A multivariate clinicopathologic study [ J ]. Hum Pathol, 1998,29(8) :791-798. 被引量:1
  • 8Tsujimura K, Hashimoto K, Kitayama H ,et al. Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site[J]. Blood, 1999,93(4) :1319-1329. 被引量:1
  • 9Seiichi H, Koji I, Yasnhiro M ,et al. Gain-of-function mutations of ckit in human gastrointestinal stromal tumors [ J]. Science, 1998,279 ( 23 ) : 577 -580. 被引量:1
  • 10Jerzy L, Marek J, Maarit SR ,et al. Mutations in exon 11 of c-KIT occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas [ J]. Am J Pathol, 1999,154( 1 ) :53-60. 被引量:1

同被引文献17

  • 1Kim SH, Kim JH, Baik GH,et al. Malignant gastrointestinal stromal tumor of the ampulla of Vater: a case report[J]. Korean J Gastroenterol, 2004,43(1):66-70. 被引量:1
  • 2Zighelboim I, Henao G, Kunda A,et al. Gastrointestinal stromal tumor presenting as a pelvic mass[J]. Gynecol Oncol, 2003,91(3):630-635. 被引量:1
  • 3Hu X, Forster J, Damjanov I. Primary malignant gastrointestinal stromal tumor of the liver[J]. Arch Pathol Lab Med. 2003,127(12): 1606-1608. 被引量:1
  • 4Larsen JB. Imatinib-a breakthrough in the treatment of gastrointestinal stromal tumors (GIST)[J]. Ugeskr Laeger,2003,165 (37):3503-3507. 被引量:1
  • 5Van oosterom AT,Judson J,Verweij E, et al .Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumours: a phase Ⅰ study[J] .The Lancet,2001,358,1 421-1 423. 被引量:1
  • 6D'Amato G,Steinert DM,McAuliffe JC, et al . Update on the biology and therapy of gastrointestinal stromal tumors[J]. Cancer Control, 2005,12(1) :44-56. 被引量:1
  • 7Bauer S,Hartmann JT,de Wit M, et al. Resection Of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment withimatinib [ J ]. Int J Cancer, 2005,117 ( 2 ) : 316-325. 被引量:1
  • 8晨智敏,皋岚湘,张红光,李雅君.上消化道间质瘤(附4例报告)[J].中国内镜杂志,1997,3(6):59-59. 被引量:1
  • 9黄春彪.十二指肠间质瘤临床病理分析[J].现代中西医结合杂志,2001,10(1):58-58. 被引量:1
  • 10成元华,杨光华,郭立新.77例胃肠道间质肿瘤的病理形态学及免疫组化研究[J].临床与实验病理学杂志,2001,17(2):123-127. 被引量:27

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部